New Key Statistics Module, Z-Score and F-Score
SZSE:301089 Key Ratios
Market Cap ¥ M | 4,415.14 |
Enterprise Value ¥ M | 3,811.21 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.81 |
Price/Sales | 12.02 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 397.00 |
EPS (TTM) ¥ | -0.54 |
Beneish M-Score | 0.59 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 24.30 |
y-y EBITDA Growth Rate % | -111.70 |
EV-to-EBIT | -40.66 |
EV-to-EBITDA | -40.66 |
PEG | -- |
Shares Outstanding M | 126.54 |
Net Margin (%) | -17.18 |
Operating Margin % | -21.05 |
Pre-tax Margin (%) | -20.23 |
Quick Ratio | 3.54 |
Current Ratio | 4.63 |
ROA % (ttm) | -3.72 |
ROE % (ttm) | -4.21 |
ROIC % (ttm) | -5.40 |
Dividend Yield % | 0.72 |
Altman Z-Score | 12.74 |
SZSE:301089 Number of Guru Trades
SZSE:301089 Volume of Guru Trades
Gurus Latest Trades with SZSE:301089
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301089 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Tuoxin Pharmaceutical Group Co Ltd Insider Transactions
No Available Data